The lung microbiome, peripheral gene expression, and recurrence-free survival after resection of stage II non-small cell lung cancer

BACKGROUND: Cancer recurrence after tumor resection in early-stage non-small cell lung cancer (NSCLC) is common, yet difficult to predict. The lung microbiota and systemic immunity may be important modulators of risk for lung cancer recurrence, yet biomarkers from the lung microbiome and peripheral...

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, Brandilyn A., Pass, Harvey I., Burk, Robert D., Xue, Xiaonan, Goparaju, Chandra, Sollecito, Christopher C., Grassi, Evan, Segal, Leopoldo N., Tsay, Jun-Chieh J., Hayes, Richard B., Ahn, Jiyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609265/
https://www.ncbi.nlm.nih.gov/pubmed/36303210
http://dx.doi.org/10.1186/s13073-022-01126-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609265/
https://www.ncbi.nlm.nih.gov/pubmed/36303210
http://dx.doi.org/10.1186/s13073-022-01126-7

Ejemplares similares